Here is the latest financial fact sheet of BAL PHARMA. For more details, see the BAL PHARMA quarterly results and BAL PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.2 |
No. of shares | m | 15.81 |
1 Week | % | 1.6 |
1 Month | % | 2.2 |
1 Year | % | 23.2 |
52 week H/L | Rs | 132.2/71.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BAL PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 109 | 79 | 73 | 149 | 134 | |
Low | Rs | 63 | 24 | 29 | 53 | 63 | |
Sales per share (Unadj.) | Rs | 158.8 | 120.7 | 169.0 | 189.8 | 193.9 | |
Earnings per share (Unadj.) | Rs | 1.5 | -9.1 | 3.2 | 3.8 | 1.7 | |
Diluted earnings per share | Rs | 1.4 | -8.2 | 3.0 | 3.6 | 1.7 | |
Cash flow per share (Unadj.) | Rs | 5.9 | -3.7 | 9.6 | 9.9 | 7.5 | |
Dividends per share (Unadj.) | Rs | 1.00 | 0 | 1.00 | 1.00 | 1.00 | |
Adj. dividends per share | Rs | 0.90 | 0.00 | 0.94 | 0.94 | 0.99 | |
Avg Dividend yield | % | 1.2 | 0 | 2.0 | 1.0 | 1.0 | |
Book value per share (Unadj.) | Rs | 47.0 | 37.0 | 35.5 | 38.9 | 40.7 | |
Adj. book value per share | Rs | 42.2 | 33.2 | 33.3 | 36.5 | 40.4 | |
Shares outstanding (eoy) | m | 14.17 | 14.17 | 14.82 | 14.82 | 15.69 | |
Price / Sales ratio | x | 0.5 | 0.4 | 0.3 | 0.5 | 0.5 | |
Avg P/E ratio | x | 56.5 | -5.6 | 16.0 | 26.2 | 59.2 | |
P/CF ratio (eoy) | x | 14.6 | -13.9 | 5.3 | 10.1 | 13.2 | |
Price / Book Value ratio | x | 1.8 | 1.4 | 1.4 | 2.6 | 2.4 | |
Dividend payout | % | 65.8 | 0 | 31.5 | 26.0 | 59.9 | |
Avg Mkt Cap | Rs m | 1,217 | 727 | 753 | 1,494 | 1,549 | |
Total wages/salary | Rs m | 503 | 504 | 419 | 473 | 553 |
BAL PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,250 | 1,711 | 2,505 | 2,812 | 3,042 | |
Other income | Rs m | 10 | 19 | 11 | 52 | 9 | |
Total revenues | Rs m | 2,260 | 1,729 | 2,517 | 2,864 | 3,052 | |
Gross profit | Rs m | 177 | 50 | 246 | 240 | 253 | |
Depreciation | Rs m | 62 | 77 | 95 | 90 | 91 | |
Interest | Rs m | 127 | 127 | 122 | 109 | 123 | |
Profit before tax | Rs m | -2 | -135 | 41 | 92 | 47 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -24 | -6 | -6 | 35 | 21 | |
Profit after tax | Rs m | 22 | -129 | 47 | 57 | 26 | |
Gross profit margin | % | 7.9 | 2.9 | 9.8 | 8.5 | 8.3 | |
Effective tax rate | % | 1,166.0 | 4.7 | -14.9 | 37.9 | 44.8 | |
Net profit margin | % | 1.0 | -7.5 | 1.9 | 2.0 | 0.9 |
BAL PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,830 | 1,574 | 1,641 | 1,846 | 2,282 | |
Current liabilities | Rs m | 1,632 | 1,595 | 1,525 | 1,656 | 2,093 | |
Net working cap to sales | % | 8.8 | -1.2 | 4.6 | 6.7 | 6.2 | |
Current ratio | x | 1.1 | 1.0 | 1.1 | 1.1 | 1.1 | |
Inventory Days | Days | 7 | 15 | 11 | 9 | 8 | |
Debtors Days | Days | 1,049 | 1,058 | 979 | 978 | 1,128 | |
Net fixed assets | Rs m | 783 | 810 | 759 | 760 | 829 | |
Share capital | Rs m | 142 | 142 | 148 | 148 | 157 | |
"Free" reserves | Rs m | 525 | 383 | 378 | 429 | 481 | |
Net worth | Rs m | 666 | 524 | 526 | 577 | 638 | |
Long term debt | Rs m | 288 | 231 | 239 | 270 | 305 | |
Total assets | Rs m | 2,613 | 2,384 | 2,401 | 2,605 | 3,110 | |
Interest coverage | x | 1.0 | -0.1 | 1.3 | 1.8 | 1.4 | |
Debt to equity ratio | x | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | |
Sales to assets ratio | x | 0.9 | 0.7 | 1.0 | 1.1 | 1.0 | |
Return on assets | % | 5.7 | -0.1 | 7.0 | 6.4 | 4.8 | |
Return on equity | % | 3.2 | -24.6 | 9.0 | 9.9 | 4.1 | |
Return on capital | % | 13.1 | -1.1 | 21.2 | 23.7 | 18.1 | |
Exports to sales | % | 56.2 | 60.5 | 60.0 | 65.3 | 66.4 | |
Imports to sales | % | 16.1 | 15.6 | 22.7 | 27.7 | 22.4 | |
Exports (fob) | Rs m | 1,266 | 1,035 | 1,504 | 1,836 | 2,020 | |
Imports (cif) | Rs m | 362 | 266 | 568 | 779 | 683 | |
Fx inflow | Rs m | 1,266 | 1,035 | 1,504 | 1,836 | 2,020 | |
Fx outflow | Rs m | 390 | 292 | 586 | 796 | 716 | |
Net fx | Rs m | 875 | 742 | 918 | 1,040 | 1,305 |
BAL PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 78 | 232 | 223 | 268 | -18 | |
From Investments | Rs m | -80 | -47 | -55 | -95 | -222 | |
From Financial Activity | Rs m | 0 | -200 | -166 | -172 | 244 | |
Net Cashflow | Rs m | -3 | -16 | 2 | 1 | 4 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Shailesh Siroya | COMP SEC: Abdul Basith | YEAR OF INC: 1987 | BSE CODE: 524824 | FV (Rs): 10 | DIV YIELD (%): 1.0 |
Read: BAL PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare BAL PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.